M. Sue O’Dorisio - Publications, H-index & Citations

M. Sue O’Dorisio

University of Iowa

46H指数

228论文数

8.8K被引数

收录论文 33

发表时间

The University of Iowa Neuroendocrine Tumor Clinic

ENDOCRINE PRACTICE

IF4.6

2025-01-01

PREAI

Howe, James R.; Menda, Yusuf; Chandrasekharan, Chandrikha; Bellizzi, Andrew M.; Quelle, Dawn E.; O'Dorisio, M. Sue; Dillon, Joseph S.

ASO Visual Abstract: Peptide Receptor Radionuclide Therapy Improves Survival in Patients Who Progress After Resection of Gastroenteropancreatic Neuroendocrine Tumors

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2024-11-23

PREAI

Borbon, Luis C.; Sherman, Scott K.; Breheny, Patrick J.; Chandrasekharan, Chandrikha; Menda, Yusuf; Bushnell, David; Bellizzi, Andrew M.; Ear, Po H.; O'Dorisio, M. Sue; O'Dorisio, Thomas M.; Dillon, Joseph S.; Howe, James R.

Peptide Receptor Radionuclide Therapy Improves Survival in Patients Who Progress After Resection of Gastroenteropancreatic Neuroendocrine Tumors

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2024-11-06

PREAI

Borbon, Luis C.; Sherman, Scott K.; Breheny, Patrick J.; Chandrasekharan, Chandrikha; Menda, Yusuf; Bushnell, David; Bellizzi, Andrew M.; Ear, P. H.; O'Dorisio, M. Sue; O'Dorisio, Thomas M.; Dillon, Joseph S.; Howe, James R.

Auranofin inhibition of thioredoxin reductase sensitizes lung neuroendocrine tumor cells (NETs) and small cell lung cancer (SCLC) cells to sorafenib as well as inhibiting SCLC xenograft growth

CANCER BIOLOGY & THERAPY

IF4.6

2024-07-25

OAAI

Johnson, Spenser S.; Liu, Dijie; Ewald, Jordan T.; Robles-Planells, Claudia; Pulliam, Casey; Christensen, Keegan A.; Bayanbold, Khaliunaa; Wels, Brian R.; Solst, Shane R.; O'Dorisio, M. Sue; Menda, Yusuf; Spitz, Douglas R.; Fath, Melissa A.

Targeting CXCR4 and Thioredoxin Reductase in High Grade Neuroendocrine Tumors & Neuroendocrine Carcinomas

FREE RADICAL BIOLOGY AND MEDICINE

IF8.2

2023-11-01

PREAI

Fath, Melissa; Spitz, Doug; Liu, Dijie; O'Dorisio, Sue; Robles-Planells, Claudia; Ewald, Jordan; Christensen, Keegan; Johnson, Spencer; Graves, Stephen A.; Menda, Yusuf

Targeting CXCR4 and thioredoxin reductase in high grade neuroendocrine tumors and neuroendocrine carcinomas

CANCER RESEARCH

IF16.6

2023-04-04

PREAI

Fath, Melissa A.; Liu, Dijie; Robles-Planells, Claudia; Ewald, Jordan T.; Christensen, Keegan A.; Johnson, Spenser S.; Graves, Stephen A.; Spitz, Douglas R.; Menda, Yusuf; O'Dorisio, M. Sue

A phase II trial to evaluate the safety and dosimetry of [177Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor (SSTR)-positive gastroenteropancreatic neuroendocrine tumours (GEP-NETs), pheochromocytomas and paragangliomas (PPGLs)

ANNALS OF ONCOLOGY

IF65.4

2021-09-01

OAAI

Gaze, M. N.; O'Dorisio, M. S.; Sabado, C.; Brouri, F.; Folitar, I.

Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors

JOURNAL OF NUCLEAR MEDICINE

IF9.1

2021-01-30

OAAI

Bushnell, David L.; Bodeker, Kellie L.; O'Dorisio, Thomas M.; Madsen, Mark T.; Menda, Yusuf; Graves, Stephen; Zamba, Gideon K. D.; O'Dorisio, M. Sue

Targeting CXCR4 and Thioredoxin Reductase in High Grade Neuroendocrine Tumors

FREE RADICAL BIOLOGY AND MEDICINE

IF8.2

2020-11-01

PREAI

Fath, Melissa; Liu, Dijie; Spitz, Doug; O'Dorisio, Sue

Clinical, Diagnostic, and Treatment Characteristics of SDHA-Related Metastatic Pheochromocytoma and Paraganglioma

FRONTIERS IN ONCOLOGY

IF3.3

2019-02-22

OAAI

Jha, Abhishek; de Luna, Kristine; Balili, Charlene Ann; Millo, Corina; Paraiso, Cecilia Angela; Ling, Alexander; Gonzales, Melissa K.; Viana, Bruna; Alrezk, Rami; Adams, Karen T.; Tena, Isabel; Chen, Alice; Neuzil, Jiri; Raygada, Margarita; Kebebew, Electron; Taieb, David; O'Dorisio, M. Sue; O'Dorisio, Thomas; Civelek, Ali Cahid; Stratakis, Constantine A.; Mercado-Asis, Leilani; Pacak, Karel

Technical Note: Single time point dose estimate for exponential clearance

MEDICAL PHYSICS

IF3.2

2018-04-16

OAAI

Madsen, Mark T.; Menda, Yusuf; O'Dorisio, Thomas M.; O'Dorisio, M. Sue

90Y-DOTATOC Dosimetry-Based Personalized Peptide Receptor Radionuclide TherapyDosimetry-

JOURNAL OF NUCLEAR MEDICINE

IF9.1

2018-03-09

OAAI

Menda, Yusuf; Madsen, Mark T.; O'Dorisio, Thomas M.; Sunderland, John J.; Watkins, G. Leonard; Dillon, Joseph S.; Mott, Sarah L.; Schultz, Michael K.; Zamba, Gideon K. D.; Bushnell, David L.; O'Dorisio, M. Sue

Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors

JOURNAL OF NUCLEAR MEDICINE

IF9.1

2017-10-12

222

OAAI

Hope, Thomas A.; Bergsland, Emily K.; Bozkurt, Murat Fani; Graham, Michael; Heaney, Anthony P.; Herrmann, Ken; Howe, James R.; Kulke, Matthew H.; Kunz, Pamela L.; Mailman, Josh; May, Lawrence; Metz, David C.; Millo, Corina; O'Dorisio, Sue; Reidy-Lagunes, Diane L.; Soulen, Michael C.; Strosberg, Jonathan R.

VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage (vol 13, pg 1, 2016)

JOURNAL OF NEUROINFLAMMATION

IF10.1

2017-08-04

OAAI

Abad, Catalina; Jayaram, Bhavaani; Becquet, Laurine; Wang, Yuqi; O'Dorisio, M. Sue; Waschek, James A.; Tan, Yossan-Var

Localization of Unknown Primary Site with 68Ga-DOTATOC PET/CT in Patients with Metastatic Neuroendocrine Tumor

JOURNAL OF NUCLEAR MEDICINE

IF9.1

2017-02-02

OAAI

Menda, Yusuf; O'Dorisio, Thomas M.; Howe, James R.; Schultz, Michael; Dillon, Joseph S.; Dick, David; Watkins, G. Leonard; Ginader, Timothy; Bushnell, David L.; Sunderland, John J.; Zamba, Gideon K. D.; Graham, Michael; O'Dorisio, M. Sue

VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage

JOURNAL OF NEUROINFLAMMATION

IF10.1

2016-06-29

OAAI

Abad, Catalina; Jayaram, Bhavaani; Becquet, Laurine; Wang, Yuki; O'Dorisio, M. Sue; Waschek, James A.; Tan, Yossan-Var

2-deoxy-D-glucose induces oxidative stress and cell killing in human neuroblastoma cells

CANCER BIOLOGY & THERAPY

IF4.6

2014-10-27

OAAI

Shutt, Damon C.; O'Dorisio, M. Sue; Aykin-Burns, Nukhet; Spitz, Douglas R.

Gene expression accurately distinguishes liver metastases of small bowel and pancreas neuroendocrine tumors

CLINICAL & EXPERIMENTAL METASTASIS

IF3.2

2014-09-21

OAAI

Sherman, Scott K.; Maxwell, Jessica E.; Carr, Jennifer C.; Wang, Donghong; Bellizzi, Andrew M.; O'Dorisio, M. Sue; O'Dorisio, Thomas M.; Howe, James R.

Feasibility and advantage of adding 131I-MIBG to 90Y-DOTATOC for treatment of patients with advanced stage neuroendocrine tumors

EJNMMI RESEARCH

IF3

2014-09-10

OAAI

Bushnell, David L.; Madsen, Mark T.; O'cdorisio, Thomas; Menda, Yusuf; Muzahir, Saima; Ryan, Randi; O'dorisio, M. Sue

Pancreastatin Predicts Survival in Neuroendocrine Tumors

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2014-04-22

OAAI

Sherman, Scott K.; Maxwell, Jessica E.; O'Dorisio, M. Sue; O'Dorisio, Thomas M.; Howe, James R.

研究方向